Nissen C, Henauer J, Speck B
Experientia. 1978 Sep 15;34(9):1219-20. doi: 10.1007/BF01922968.
Adenine-arabinoside, a new antiviral drug with questionable bone marrow toxicity, inhibits colony formation by myeloid precursor cells in vitro. Compared to cytosine-arabinoside this cytotoxicity is roughly one third.